{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.decomposition import LatentDirichletAllocation\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "from sklearn.metrics import f1_score\n",
    "from itertools import cycle, islice\n",
    "from operator import itemgetter\n",
    "import sif_embedding_wrapper\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import itertools\n",
    "import codecs\n",
    "import utils\n",
    "import os"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from gensim.models.keyedvectors import KeyedVectors\n",
    "\n",
    "# model = KeyedVectors.load_word2vec_format('/home/stirunag/models/model_OTAR_200d-3mc-10it.bin', binary=True)\n",
    "# model.save_word2vec_format('/home/stirunag/pre-trained_word_embeddings/model_OTAR_200d-3mc-10it.txt', binary=False)\n",
    "\n",
    "# sed -i -n -e '2,$p'file.txt to remove first line from the txt file\n",
    "\n",
    "\n",
    "# words, embs, weight4ind = sif_embedding_wrapper.load_embeddings(\"/home/stirunag/pre-trained_word_embeddings/model_OTAR_200d-3mc-10it.txt\", \n",
    "#                                                      '/home/stirunag/pre-trained_word_embeddings/OTAR/TF.txt')\n",
    "\n",
    "\n",
    "# words, embs, weight4ind = sif_embedding_wrapper.load_embeddings(\"/home/stirunag/pre-trained_word_embeddings/PubMed-and-PMC-FS.txt\", \n",
    "#                                                      '/home/stirunag/pre-trained_word_embeddings/wiki/enwiki_vocab_min200.txt')\n",
    "\n",
    "words, embs, weight4ind = sif_embedding_wrapper.load_embeddings(\"/home/stirunag/pre-trained_word_embeddings/glove/glove.6B.300d.txt\", \n",
    "                                                      '/home/stirunag/pre-trained_word_embeddings/wiki/enwiki_vocab_min200.txt')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# get the current working directory\n",
    "data_path = os.path.abspath(os.path.join(os.path.dirname( '__file__' ), '..', 'Datasets'))+'/'\n",
    "\n",
    "# Although the dataset says csv, it is tab delimited. In addition to this, they have severe codels problems. \n",
    "# So best to parse throught codes first. \n",
    "# UnicodeDecodeError: 'utf-8' codec can't decode byte 0xfc in position 2: invalid start byte\n",
    "\n",
    "#open for reading with \"universal\" type set\n",
    "\n",
    "import codecs\n",
    "\n",
    "doc_d_t = codecs.open(data_path+'EUADR_Corpus_IBIgroup/'+'EUADR_drug_target'+'.csv','rU','UTF-8') \n",
    "EUADR_drug_target = pd.read_csv(doc_d_t, sep='\\t', na_filter = False)\n",
    "EUADR_drug_target['CLASS'] = 'drug_gene'\n",
    "\n",
    "doc_t_d = codecs.open(data_path+'EUADR_Corpus_IBIgroup/'+'EUADR_target_disease'+'.csv','rU','UTF-8',errors='ignore') \n",
    "EUADR_target_disease = pd.read_csv(doc_t_d, sep='\\t', na_filter = False)\n",
    "EUADR_target_disease['CLASS'] = 'gene_disease'\n",
    "       \n",
    "doc_d_d = codecs.open(data_path+'EUADR_Corpus_IBIgroup/'+'EUADR_drug_disease'+'.csv','rU','UTF-8')                       \n",
    "EUADR_drug_disease = pd.read_csv(doc_d_d, sep='\\t', na_filter = False)\n",
    "EUADR_drug_disease['CLASS'] = 'drug_disease'\n",
    "\n",
    "\n",
    "EUADR_temp = EUADR_drug_target.append(EUADR_target_disease).append(EUADR_drug_disease)\n",
    "\n",
    "EUADR_temp_1 = EUADR_temp[EUADR_temp['ASSOCIATION_TYPE'] == 'PA']\n",
    "EUADR_temp_2 = EUADR_temp[EUADR_temp['ASSOCIATION_TYPE'] == 'NA']\n",
    "EUADR_temp = EUADR_temp_1.append(EUADR_temp_2)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Get GAD dataset\n",
    "\n",
    "doc_t_d = codecs.open(data_path+'GAD_Corpus_IBIgroup/'+'GAD_Y_N'+'.csv','rU','UTF-8',errors='ignore') \n",
    "GAD_target_disease_Y_N = pd.read_csv(doc_t_d, sep='\\t', na_filter = False)\n",
    "GAD_target_disease_Y_N['CLASS'] = 'gene_disease'\n",
    "\n",
    "doc_t_d = codecs.open(data_path+'GAD_Corpus_IBIgroup/'+'GAD_F'+'.csv','rU','UTF-8',errors='ignore') \n",
    "GAD_target_disease_F = pd.read_csv(doc_t_d, sep='\\t', na_filter = False)\n",
    "GAD_target_disease_F['CLASS'] = 'gene_disease'\n",
    "\n",
    "GAD_temp = GAD_target_disease_Y_N\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "EUADR_temp.reset_index(inplace=True)\n",
    "\n",
    "doc_embeddings = sif_embedding_wrapper.sentences2vecs(EUADR_temp[\"SENTENCE\"], embs, words, weight4ind)\n",
    "EUADR_temp[\"vector\"] = pd.Series(list(doc_embeddings))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['level_0', 'index', 'ASSOCIATION_TYPE', 'PMID', 'NUM_SENTENCE',\n",
       "       'ENTITY1_TEXT', 'ENTITY1_INI', 'ENTITY1_END', 'ENTITY1_TYPE',\n",
       "       'ENTITY2_TEXT', 'ENTITY2_INI', 'ENTITY2_END', 'ENTITY2_TYPE',\n",
       "       'SENTENCE', 'CLASS', 'vector'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "EUADR_temp.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['PA', 'NA']"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ground_truth = {}\n",
    "\n",
    "for idx, row in EUADR_temp.iterrows():\n",
    "    ground_truth[idx] = row['ASSOCIATION_TYPE']\n",
    "\n",
    "categories = list(EUADR_temp[\"ASSOCIATION_TYPE\"].unique())\n",
    "categories    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "ground_truth = {}\n",
    "for idx, row in EUADR_temp.iterrows():\n",
    "    ground_truth[idx] = row['ASSOCIATION_TYPE'] \n",
    "\n",
    "inv_map = {}\n",
    "for k, v in ground_truth.items():\n",
    "    inv_map[v] = inv_map.get(v, [])\n",
    "    inv_map[v].append(k)\n",
    "\n",
    "# inv_map"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Get average/mean of the sentence vectors that represent our topics \n",
    "category_vecs = {}\n",
    "for c in categories:\n",
    "    vectors = np.asarray(list(EUADR_temp.loc[EUADR_temp.index.isin(inv_map[c])].vector))\n",
    "    category_vecs[c] = np.mean(vectors, axis=0)\n",
    "\n",
    "    \n",
    "# category_vecs    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Try to predict the label of unknown sentences\n",
    "\n",
    "predictions = {}\n",
    "\n",
    "selected_idx = [j for i in inv_map.values() for j in i]\n",
    "\n",
    "for idx, row in EUADR_temp.iterrows():\n",
    "    if idx in selected_idx:\n",
    "        max_sim = 0\n",
    "        winner = 'other'\n",
    "        for j in category_vecs:\n",
    "            sim = cosine_similarity(row[\"vector\"].reshape(1, -1), category_vecs[j].reshape(1, -1)).flatten()[0]\n",
    "            if sim > max_sim:\n",
    "                max_sim = sim\n",
    "                winner = j\n",
    "        predictions[idx] = winner\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.8473489469889198"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def get_accuracy_score(predictions, truth_dict):\n",
    "    preds = []\n",
    "    labels = []\n",
    "    mis_classified = []\n",
    "    mis_pred = []\n",
    "    \n",
    "    for k,v in predictions.items():\n",
    "        preds.append(v)\n",
    "        labels.append(truth_dict[k])\n",
    "        if v!=truth_dict[k]:\n",
    "#             print(str(v) + '--x--' + str(truth_dict[k]))\n",
    "            mis_pred.append(str(v))\n",
    "            mis_classified.append(k)\n",
    "\n",
    "    return f1_score(labels, preds, average='weighted'), mis_classified, mis_pred\n",
    "\n",
    "\n",
    "score, miss_classified_df, miss_pred = get_accuracy_score(predictions, ground_truth)\n",
    "score"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>SENTENCE</th>\n",
       "      <th>ASSOCIATION_TYPE</th>\n",
       "      <th>Predicted-CLASS</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Together, our results suggest that dexrazoxane antagonizes doxorubicin-induced DNA damage through its interference with Top2beta, which could implicate Top2beta in doxorubicin cardiotoxicity.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>The FOS diet increased expression of TRPV6 and calbindin-D9k but did not affect PMCA1b expression.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>The FOS diet increased expression of TRPV6 and calbindin-D9k but did not affect PMCA1b expression.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>On the one hand, endocannabinoids have been implicated in the protective effects of IPC through cannabinoid CB1/CB2 receptor-dependent and -independent mechanisms.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>Among these active compounds, 3',4',7-trimethoxyflavone showed the strongest anti-BCRP activity with RI(50) values of 0.012 microM for SN-38 and 0.044 muM for mitoxantrone.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>All three groups showed similar sensitivity to the cytotoxic effects of cytarabine but FLT3/ITD mutant level was inversely correlated with cytarabine cytotoxicity (P = 0.04) whereas FLT3/TKD mutant level had no impact.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145</th>\n",
       "      <td>CBT-1 was found to compete [(125)I]-IAAP labeling of Pgp with an IC(50) of 0.14 microM, and low concentrations of CBT-1 (&lt;1 microM) stimulated Pgp-mediated ATP hydrolysis.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>Ropivacaine and one of its metabolites, pipecoloxylidide, inhibit CYP2D6 in.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>Ropivacaine and one of its metabolites, pipecoloxylidide, inhibit CYP2D6 in.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>On multivariate analysis the CYP3A5 A6986G genotype *3/*3 (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for leukocytopenia (grade 3 or greater) throughout the period of chemotherapy.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>This study assessed associations between the CYP4F2 gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>For men, G allele frequency of rs2108622 and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for MI patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>When stratified by ALDH2 Ex1+82A&gt;G polymorphism, alcohol-related increases in stomach cancer risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>This study is the first to confirm the association between COL1A2 and IAs.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>Interestingly, the diplotype TTAC/CCAG also conferred an increased risk of HCC (OR 1.76, 95% CI 1.22-2.54, P=0.003).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of HCC (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of HCC (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190</th>\n",
       "      <td>The 5T5T genotype at MMP-3 SNP -1613 5T/6T increased the chance of stenotic complications in CD during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>339</th>\n",
       "      <td>We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>341</th>\n",
       "      <td>We found evidence of association with acute-onset, but not slow-onset and fulminant, type 1 diabetes for two of the four single-nucleotide polymorphisms genotyped (rs706778 and rs3118470).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>342</th>\n",
       "      <td>We found evidence of association with acute-onset, but not slow-onset and fulminant, type 1 diabetes for two of the four single-nucleotide polymorphisms genotyped (rs706778 and rs3118470).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>347</th>\n",
       "      <td>DNA repair gene polymorphisms, such as those of XRCC3 and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to carcinogenesis.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>356</th>\n",
       "      <td>The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>357</th>\n",
       "      <td>The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>358</th>\n",
       "      <td>The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>359</th>\n",
       "      <td>The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>361</th>\n",
       "      <td>IL-22R1 mRNA was expressed in 100% of the controls and CRSsNP.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>However, IL-22R1 was only expressed in 55% of patients with recalcitrant CRSwNP.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>Additionally, levels of IL22R1 were significantly lower in recalcitrant CRSwNP compared to controls and CRSsNP.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>390</th>\n",
       "      <td>Mean pain (mm) recorded before injection, before reduction, and after reduction in the intra-articular lidocaine group was 84.3 (95% confidence interval (CI) 79.8 to 88.8), 52.6 (95% CI 45.2 to 60.1), and 27.3 (95% CI 19.9 to 34.7), respectively.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>412</th>\n",
       "      <td>Calculated detectable differences for mortality/fatal malignancy with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>413</th>\n",
       "      <td>Calculated detectable differences for mortality/fatal malignancy with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>414</th>\n",
       "      <td>Calculated detectable differences for mortality/fatal malignancy with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>418</th>\n",
       "      <td>5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>419</th>\n",
       "      <td>The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis-associated neoplasia.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>420</th>\n",
       "      <td>Administration of 75 mg/kg 5-ASA decreased both the mean multiplicity of flat dysplasias (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias (tumor burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>421</th>\n",
       "      <td>An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg 5-ASA exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>422</th>\n",
       "      <td>Administration of 75 mg/kg 5-ASA decreased both the mean multiplicity of flat dysplasias (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias (tumor burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>423</th>\n",
       "      <td>An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg 5-ASA exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>454</th>\n",
       "      <td>Contrarily, LABA showed a significant increase in asthma-related deaths (Relative Risk=3.83; 95% CI, 1.21-12.14).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>In multivariate analysis the risk of anaemia was significantly associated with zidovudine (OR, 3.27 95% CI, 1.64-6.54, P = 0.0008) and peg-IFN (OR, 2.35; 95% CI, 1.16-4.57, P = 0.0179).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>500</th>\n",
       "      <td>Results - The topiramate group showed a reduction in the mean (+/-SD) of monthly migraine frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, headache intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P &lt; 0.001).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>501</th>\n",
       "      <td>Results - The topiramate group showed a reduction in the mean (+/-SD) of monthly migraine frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, headache intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P &lt; 0.001).</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>534</th>\n",
       "      <td>In contrast to the metabolic syndrome, GnRH agonists increase subcutaneous fat mass, HDL cholesterol, and adiponectin, and do not alter the waist-to-hip ratio, blood pressure, or C-reactive protein level.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>535</th>\n",
       "      <td>We demonstrated that RZG beneficial effects on insulin secretion and apoptosis did not imply PDX-1 or insulin gene modulation.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>536</th>\n",
       "      <td>We demonstrated that RZG beneficial effects on insulin secretion and apoptosis did not imply PDX-1 or insulin gene modulation.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>557</th>\n",
       "      <td>We found no evidence of impaired control of the carbohydrate and lipid metabolism or aggravation of vascular lesions during the two years an etonogestrel implant was used by diabetic women.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>558</th>\n",
       "      <td>Data of our study revealed an unexpected high rate of hypogonadism irrespective of cyclophosphamide use, and subclinical involvement of the testes by the vasculitis itself might be an alternative explanation.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>118 rows Ã— 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                               SENTENCE  \\\n",
       "21   Together, our results suggest that dexrazoxane antagonizes doxorubicin-induced DNA damage through its interference with Top2beta, which could implicate Top2beta in doxorubicin cardiotoxicity.                                                                                                                                                                                                                                                      \n",
       "26   The FOS diet increased expression of TRPV6 and calbindin-D9k but did not affect PMCA1b expression.                                                                                                                                                                                                                                                                                                                                                   \n",
       "27   The FOS diet increased expression of TRPV6 and calbindin-D9k but did not affect PMCA1b expression.                                                                                                                                                                                                                                                                                                                                                   \n",
       "31   [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.                                                                                                                                                                                                                                                                                              \n",
       "36   Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A.                                                                                                                                                                                                                                                                                                                                                             \n",
       "61   On the one hand, endocannabinoids have been implicated in the protective effects of IPC through cannabinoid CB1/CB2 receptor-dependent and -independent mechanisms.                                                                                                                                                                                                                                                                                  \n",
       "97   Among these active compounds, 3',4',7-trimethoxyflavone showed the strongest anti-BCRP activity with RI(50) values of 0.012 microM for SN-38 and 0.044 muM for mitoxantrone.                                                                                                                                                                                                                                                                         \n",
       "100  We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).                                                                \n",
       "101  We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).                                                                \n",
       "104  We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).                                                                \n",
       "105  We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).                                                                \n",
       "117  All three groups showed similar sensitivity to the cytotoxic effects of cytarabine but FLT3/ITD mutant level was inversely correlated with cytarabine cytotoxicity (P = 0.04) whereas FLT3/TKD mutant level had no impact.                                                                                                                                                                                                                           \n",
       "145  CBT-1 was found to compete [(125)I]-IAAP labeling of Pgp with an IC(50) of 0.14 microM, and low concentrations of CBT-1 (<1 microM) stimulated Pgp-mediated ATP hydrolysis.                                                                                                                                                                                                                                                                          \n",
       "153  Ropivacaine and one of its metabolites, pipecoloxylidide, inhibit CYP2D6 in.                                                                                                                                                                                                                                                                                                                                                                         \n",
       "155  Ropivacaine and one of its metabolites, pipecoloxylidide, inhibit CYP2D6 in.                                                                                                                                                                                                                                                                                                                                                                         \n",
       "160  On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients.   \n",
       "162  Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.                                                                                                                                                                                                                                                                                 \n",
       "163  Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.                                                                                                                                                                                                                                                                                 \n",
       "166  On multivariate analysis the CYP3A5 A6986G genotype *3/*3 (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for leukocytopenia (grade 3 or greater) throughout the period of chemotherapy.                                                                                                                                                        \n",
       "169  This study assessed associations between the CYP4F2 gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).                                                                                                                                                                     \n",
       "171  For men, G allele frequency of rs2108622 and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for MI patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).                                                                                                                                                                                                \n",
       "172  When stratified by ALDH2 Ex1+82A>G polymorphism, alcohol-related increases in stomach cancer risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.                                                                                                                       \n",
       "175  This study is the first to confirm the association between COL1A2 and IAs.                                                                                                                                                                                                                                                                                                                                                                           \n",
       "179  Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis.                                                                                                                                                                                                                                                                                                                                    \n",
       "182  Interestingly, the diplotype TTAC/CCAG also conferred an increased risk of HCC (OR 1.76, 95% CI 1.22-2.54, P=0.003).                                                                                                                                                                                                                                                                                                                                 \n",
       "183  To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of HCC (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.                                                                                                                                                                \n",
       "184  To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of HCC (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.                                                                                                                                                                \n",
       "188  The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).                                                                                                                                                  \n",
       "189  The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).                                                                                                                                                  \n",
       "190  The 5T5T genotype at MMP-3 SNP -1613 5T/6T increased the chance of stenotic complications in CD during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).                                                                                                                                                               \n",
       "..                                                                                                                                                                                                                                                                                      ...                                                                                                                                                               \n",
       "339  We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.                                                                                                                                                                                                                                               \n",
       "341  We found evidence of association with acute-onset, but not slow-onset and fulminant, type 1 diabetes for two of the four single-nucleotide polymorphisms genotyped (rs706778 and rs3118470).                                                                                                                                                                                                                                                         \n",
       "342  We found evidence of association with acute-onset, but not slow-onset and fulminant, type 1 diabetes for two of the four single-nucleotide polymorphisms genotyped (rs706778 and rs3118470).                                                                                                                                                                                                                                                         \n",
       "347  DNA repair gene polymorphisms, such as those of XRCC3 and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to carcinogenesis.                                                                                                                                                                                                                                                                                             \n",
       "356  The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.                                                                                               \n",
       "357  The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.                                                                                               \n",
       "358  The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.                                                                                               \n",
       "359  The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.                                                                                               \n",
       "361  IL-22R1 mRNA was expressed in 100% of the controls and CRSsNP.                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "362  However, IL-22R1 was only expressed in 55% of patients with recalcitrant CRSwNP.                                                                                                                                                                                                                                                                                                                                                                     \n",
       "363  Additionally, levels of IL22R1 were significantly lower in recalcitrant CRSwNP compared to controls and CRSsNP.                                                                                                                                                                                                                                                                                                                                      \n",
       "390  Mean pain (mm) recorded before injection, before reduction, and after reduction in the intra-articular lidocaine group was 84.3 (95% confidence interval (CI) 79.8 to 88.8), 52.6 (95% CI 45.2 to 60.1), and 27.3 (95% CI 19.9 to 34.7), respectively.                                                                                                                                                                                               \n",
       "412  Calculated detectable differences for mortality/fatal malignancy with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.                                                                                                                                                                                                                                           \n",
       "413  Calculated detectable differences for mortality/fatal malignancy with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.                                                                                                                                                                                                                                           \n",
       "414  Calculated detectable differences for mortality/fatal malignancy with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.                                                                                                                                                                                                                                           \n",
       "418  5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.                                                                                                                                                                                                                                                                                                   \n",
       "419  The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis-associated neoplasia.                                                                                                                                                                                                                                                                              \n",
       "420  Administration of 75 mg/kg 5-ASA decreased both the mean multiplicity of flat dysplasias (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias (tumor burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).                                                                                                   \n",
       "421  An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg 5-ASA exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).                                                                                                                                                        \n",
       "422  Administration of 75 mg/kg 5-ASA decreased both the mean multiplicity of flat dysplasias (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias (tumor burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).                                                                                                   \n",
       "423  An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg 5-ASA exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).                                                                                                                                                        \n",
       "454  Contrarily, LABA showed a significant increase in asthma-related deaths (Relative Risk=3.83; 95% CI, 1.21-12.14).                                                                                                                                                                                                                                                                                                                                    \n",
       "494  In multivariate analysis the risk of anaemia was significantly associated with zidovudine (OR, 3.27 95% CI, 1.64-6.54, P = 0.0008) and peg-IFN (OR, 2.35; 95% CI, 1.16-4.57, P = 0.0179).                                                                                                                                                                                                                                                            \n",
       "500  Results - The topiramate group showed a reduction in the mean (+/-SD) of monthly migraine frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, headache intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001).                                                                                                               \n",
       "501  Results - The topiramate group showed a reduction in the mean (+/-SD) of monthly migraine frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, headache intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001).                                                                                                               \n",
       "534  In contrast to the metabolic syndrome, GnRH agonists increase subcutaneous fat mass, HDL cholesterol, and adiponectin, and do not alter the waist-to-hip ratio, blood pressure, or C-reactive protein level.                                                                                                                                                                                                                                         \n",
       "535  We demonstrated that RZG beneficial effects on insulin secretion and apoptosis did not imply PDX-1 or insulin gene modulation.                                                                                                                                                                                                                                                                                                                       \n",
       "536  We demonstrated that RZG beneficial effects on insulin secretion and apoptosis did not imply PDX-1 or insulin gene modulation.                                                                                                                                                                                                                                                                                                                       \n",
       "557  We found no evidence of impaired control of the carbohydrate and lipid metabolism or aggravation of vascular lesions during the two years an etonogestrel implant was used by diabetic women.                                                                                                                                                                                                                                                        \n",
       "558  Data of our study revealed an unexpected high rate of hypogonadism irrespective of cyclophosphamide use, and subclinical involvement of the testes by the vasculitis itself might be an alternative explanation.                                                                                                                                                                                                                                     \n",
       "\n",
       "    ASSOCIATION_TYPE Predicted-CLASS  \n",
       "21   PA               NA              \n",
       "26   PA               NA              \n",
       "27   PA               NA              \n",
       "31   PA               NA              \n",
       "36   PA               NA              \n",
       "61   PA               NA              \n",
       "97   PA               NA              \n",
       "100  PA               NA              \n",
       "101  PA               NA              \n",
       "104  PA               NA              \n",
       "105  PA               NA              \n",
       "117  PA               NA              \n",
       "145  PA               NA              \n",
       "153  PA               NA              \n",
       "155  PA               NA              \n",
       "160  PA               NA              \n",
       "162  PA               NA              \n",
       "163  PA               NA              \n",
       "166  PA               NA              \n",
       "169  PA               NA              \n",
       "171  PA               NA              \n",
       "172  PA               NA              \n",
       "175  PA               NA              \n",
       "179  PA               NA              \n",
       "182  PA               NA              \n",
       "183  PA               NA              \n",
       "184  PA               NA              \n",
       "188  PA               NA              \n",
       "189  PA               NA              \n",
       "190  PA               NA              \n",
       "..   ..               ..              \n",
       "339  PA               NA              \n",
       "341  PA               NA              \n",
       "342  PA               NA              \n",
       "347  PA               NA              \n",
       "356  PA               NA              \n",
       "357  PA               NA              \n",
       "358  PA               NA              \n",
       "359  PA               NA              \n",
       "361  PA               NA              \n",
       "362  PA               NA              \n",
       "363  PA               NA              \n",
       "390  PA               NA              \n",
       "412  PA               NA              \n",
       "413  PA               NA              \n",
       "414  PA               NA              \n",
       "418  PA               NA              \n",
       "419  PA               NA              \n",
       "420  PA               NA              \n",
       "421  PA               NA              \n",
       "422  PA               NA              \n",
       "423  PA               NA              \n",
       "454  PA               NA              \n",
       "494  PA               NA              \n",
       "500  PA               NA              \n",
       "501  PA               NA              \n",
       "534  NA               PA              \n",
       "535  NA               PA              \n",
       "536  NA               PA              \n",
       "557  NA               PA              \n",
       "558  NA               PA              \n",
       "\n",
       "[118 rows x 3 columns]"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_colwidth', -1)\n",
    "\n",
    "miss_calssified_df = EUADR_temp.iloc[miss_classified_df , [13,2]] \n",
    "miss_calssified_df['Predicted-CLASS'] = miss_pred\n",
    "miss_calssified_df\n",
    "\n",
    "# result_path = os.path.abspath(os.path.join(os.path.dirname( '__file__' ), '..', 'Results'))+'/'\n",
    "# miss_calssified_df.to_csv(result_path+'miss_predictions_train.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['index', 'GAD_ID', 'GAD_ASSOC', 'GAD_GENE_SYMBOL', 'GAD_GENE_NAME',\n",
       "       'GAD_ENTREZ_ID', 'NER_GENE_ENTITY', 'NER_GENE_OFFSET',\n",
       "       'GAD_DISEASE_NAME', 'NER_DISEASE_ENTITY', 'NER_DISEASE_OFFSET',\n",
       "       'GAD_CONCLUSION', 'CLASS', 'vector'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "GAD_temp.reset_index(inplace=True)\n",
    "\n",
    "doc_embeddings = sif_embedding_wrapper.sentences2vecs(GAD_temp[\"GAD_CONCLUSION\"], embs, words, weight4ind)\n",
    "GAD_temp[\"vector\"] = pd.Series(list(doc_embeddings))\n",
    "\n",
    "GAD_temp['GAD_ASSOC'] = GAD_temp['GAD_ASSOC'].apply(lambda x: x.replace('Y', 'PA').replace('N', 'NA').replace('F', 'FA'))\n",
    "GAD_temp.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.6001470488721178"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "GAD_test_ground_truth = {}\n",
    "\n",
    "for idx, row in GAD_temp.iterrows():\n",
    "    GAD_test_ground_truth[idx] = row['GAD_ASSOC']\n",
    "    \n",
    "# Try to predict the label of unknown sentences\n",
    "\n",
    "GAD_test_predictions = {}\n",
    "\n",
    "for idx, row in GAD_temp.iterrows():\n",
    "    max_sim = 0.00\n",
    "    winner = 'other'\n",
    "    for j in category_vecs:\n",
    "        sim = cosine_similarity(row[\"vector\"].reshape(1, -1), category_vecs[j].reshape(1, -1)).flatten()[0]\n",
    "        if sim > max_sim:\n",
    "            max_sim = sim\n",
    "            winner = j\n",
    "    GAD_test_predictions[idx] = winner   \n",
    "    \n",
    "    \n",
    "GAD_score, GAD_miss_classified, GAD_miss_pred = get_accuracy_score(GAD_test_predictions, GAD_test_ground_truth)\n",
    "GAD_score    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>GAD_CONCLUSION</th>\n",
       "      <th>GAD_ASSOC</th>\n",
       "      <th>Predicted-CLASS</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>These results suggest that the C1772T polymorphism in HIF-1alpha is not involved in progression or metastasis of colorectal carcinoma.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>In our setting, iron overload among alcoholic individuals seems to be independent of the presence of mutations C282Y, H63D and S65C in the HFE gene.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>These three studies do not provide consistent evidence supporting the hypothesis that HFE mutations are associated with an increased risk of cardiovascular disease and with the development of arteriosclerosis.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>We conclude that  homozygosity for the G1514--&gt;A mutation is exclusively responsible for the adult form of Sandhoff disease in this family, and that the A619--&gt;G substitution is not a deleterious mutation but rather a common HEXB polymorphism.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Our findings suggest that the genetic variants of the TIM-1 but not the TIM-3 gene contribute to asthma susceptibility in this African-American population.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>These findings suggest that individual susceptibility to bladder cancer may be modulated by GSTM1, GSTT1 and NAT2 polymorphisms.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>These results support previous reports that the GSTM1 null genotype is associated with a modest increase in risk for lung cancer, particularly among heavy smokers, suggest no role for GSTT1 and the need for further study of GSTP1.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Individuals who bear GSTT1 0/0 genotype or GSTT1 0/0-GSTM1 0/0 combined genotypes are more susceptible to leukemia, especially for male and younger carriers.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Individuals who bear GSTT1 0/0 genotype or GSTT1 0/0-GSTM1 0/0 combined genotypes are more susceptible to leukemia, especially for male and younger carriers.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>There is a synergy of susceptible genotypes GSTM1 0/0 and CYP1A1 Val/Val or CYP1A1 Ile/Val to enhance the individual susceptibility to lung cancer.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Individuals who bear GSTT1 0/0 genotype or GSTT1 0/0-GSTM1 0/0 combined genotypes are more susceptible to leukemia, especially for male and younger carriers.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Our results through Meta-analysis did not support the association between GSTM1 null genotype and esophageal cancer, but the smokers carring the GSTM1 null genotype might be associated with the increased risk of esophageal cancer.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Our results through Meta-analysis did not support the association between GSTM1 null genotype and esophageal cancer, but the smokers carring the GSTM1 null genotype might be associated with the increased risk of esophageal cancer.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Our results through Meta-analysis did not support the association between GSTM1 null genotype and esophageal cancer, but the smokers carring the GSTM1 null genotype might be associated with the increased risk of esophageal cancer.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Our results through Meta-analysis did not support the association between GSTM1 null genotype and esophageal cancer, but the smokers carring the GSTM1 null genotype might be associated with the increased risk of esophageal cancer.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Because our samples provided quite high power, these results indicate that GSK3B may not play a major role in Japanese schizophrenia.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Examination of our own data and those of other groups leads us to conclude that at present, GRM3 should not be viewed as a gene for which there is replicated evidence for association with schizophrenia.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Results indicate that genomic variations of the GRIN1 gene are not likely to be involved substantially in the etiology of schizophrenia.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>revealed no significant association between schizophrenia and the SNPs in the upstream region of GRIN1, these SNPs apparently do not play a critical role in the pathogenesis of schizophrenia in the Japanese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>revealed no significant association between schizophrenia and the SNPs in the upstream region of GRIN1, these SNPs apparently do not play a critical role in the pathogenesis of schizophrenia in the Japanese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>We conclude that  GRIK2 does not play a major role in the pathogenesis of schizophrenia in the Japanese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>We conclude that  GRIK2 does not play a major role in the pathogenesis of schizophrenia in the Japanese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>We conclude that  GRIK1 does not play a major role in schizophrenia pathogenesis in the Japanese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>We conclude that  GRIK1 does not play a major role in schizophrenia pathogenesis in the Japanese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Our results suggest that the three SNPs of GRIA4 are unlikely to play a major role in the susceptibility to schizophrenia in the Chinese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>The result of this study suggests that the GPX1 genotype is unlikely to be associated with the risk of developing prostate cancer.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>The results of the current study suggest that genetic polymorphisms in the proximal promoter region and in the fourth intron of the GH1 gene are unrelated to breast carcinoma risk in Chinese women.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>Overall, we obtained no solid evidence for the involvement of the GDNF gene in the pathogenesis of schizophrenia, although further studies in larger numbers of subjects will be required to conclude whether the trinucleotide repeat polymorphism is associated with the development of schizophrenia.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>Overall, we obtained no solid evidence for the involvement of the GDNF gene in the pathogenesis of schizophrenia, although further studies in larger numbers of subjects will be required to conclude whether the trinucleotide repeat polymorphism is associated with the development of schizophrenia.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>Our results suggest that GCK gene was associated with Chinese GDM, and haplotype of GCK1/GCK2 B/2 was a protective factor for GDM.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2745</th>\n",
       "      <td>Thus, TAP1 and TAP2 genes polymorphism are not linked to cervical carcinoma, since no association was found between a particular genotype and the disease.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2746</th>\n",
       "      <td>This pilot study does not support involvement of the GNAS1 polymorphism in prostate cancer risk.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2747</th>\n",
       "      <td>Our findings suggest that the GLO1 gene is unlikely a major susceptible gene for autism in an ethnic Chinese population from Taiwan.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2748</th>\n",
       "      <td>Thus, TAP1 and TAP2 genes polymorphism are not linked to cervical carcinoma, since no association was found between a particular genotype and the disease.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2749</th>\n",
       "      <td>there is no evidence that either GATA3 rs570613, or any variant in strong linkage disequilibrium with it, is associated with breast cancer risk in women.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2750</th>\n",
       "      <td>Study results do not demonstrate an association between ACE ID polymorphism and colorectal cancer in our patients.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2751</th>\n",
       "      <td>our data suggest that GST and CYP1A1 genotypes are not associated with the susceptibility to prostate cancer or its outcome in the Brazilian population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2754</th>\n",
       "      <td>The results suggest that the CNP gene may not be involved in the etiology and pathology of schizophrenia in the Chinese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2755</th>\n",
       "      <td>These results suggest that the variants within the promoter region of QKI gene are unlikely to play a major role in susceptibility to schizophrenia in the Chinese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2756</th>\n",
       "      <td>trace amine associated receptor 6 is not important for the development of schizophrenia in our family samples.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2758</th>\n",
       "      <td>Although rs7566605 was not significantly associated with obesity in our study population, we can not rule out the involvement of INSIG2 in obesity related traits as we found significant association of another tagSNP in INSIG2 with both BMI and ABDCIR.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2759</th>\n",
       "      <td>Although rs7566605 was not significantly associated with obesity in our study population, we can not rule out the involvement of INSIG2 in obesity related traits as we found significant association of another tagSNP in INSIG2 with both BMI and ABDCIR.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2760</th>\n",
       "      <td>Although rs7566605 was not significantly associated with obesity in our study population, we can not rule out the involvement of INSIG2 in obesity related traits as we found significant association of another tagSNP in INSIG2 with both BMI and ABDCIR.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2761</th>\n",
       "      <td>Although rs7566605 was not significantly associated with obesity in our study population, we can not rule out the involvement of INSIG2 in obesity related traits as we found significant association of another tagSNP in INSIG2 with both BMI and ABDCIR.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2771</th>\n",
       "      <td>Our findings suggest a relevant role of ADAM33 in thepathogenesis of asthma in this population.</td>\n",
       "      <td>PA</td>\n",
       "      <td>NA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2773</th>\n",
       "      <td>These results do not support the hypothesis that TGFB1 L10P genotypes modify the risk of breast cancer in BRCA1 or BRCA2 mutation carriers.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2776</th>\n",
       "      <td>MnSOD polymorphisms play no role in the genetic predisposition to oesophageal cancer.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2777</th>\n",
       "      <td>These results do not support the hypothesis that TGFB1 L10P genotypes modify the risk of breast cancer in BRCA1 or BRCA2 mutation carriers.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2778</th>\n",
       "      <td>These results do not support the hypothesis that TGFB1 L10P genotypes modify the risk of breast cancer in BRCA1 or BRCA2 mutation carriers.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2779</th>\n",
       "      <td>There was no evidence of an association between the cSHMT genotype and breast cancer occurrence.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2780</th>\n",
       "      <td>BIK might not play a major role in the susceptibility of schizophrenia in Japanese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2781</th>\n",
       "      <td>The present study provides no positive evidence for the association between the RyR3 gene and autism in the Japanese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2782</th>\n",
       "      <td>These results suggest that unlike for other cancer types, the hOGG1 Ser326Cys polymorphism is not a major genetic risk factor for colorectal cancer.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2786</th>\n",
       "      <td>These results suggest that the HSD3B1 N367T and UGT2B17 null polymorphisms may modify the risk of prostate cancer, particularly among men with a family history of the disease.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2791</th>\n",
       "      <td>This study did not show an association between common variants of CREG and CAD in the northern Chinese Han population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2793</th>\n",
       "      <td>the Trp(64)Arg mutation of ADRB3 has little or no influence on either body weight or body mass index in the general Japanese population.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2795</th>\n",
       "      <td>Our results suggested that the Val158Met polymorphism of COMT was not associated with the risk of sporadic or latent prostate cancer in Japanese men.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2798</th>\n",
       "      <td>The UGT2B17 deletion polymorphism does not play a major role in prostate cancer susceptibility as previously indicated.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2799</th>\n",
       "      <td>Our findings suggest that the p53 codon 72 polymorphism is unlikely to be associated with endometriosis in Japanese women.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2800</th>\n",
       "      <td>Our data suggest both TNF and LTA genes are not major susceptibility genes for endometriosis.</td>\n",
       "      <td>NA</td>\n",
       "      <td>PA</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1039 rows Ã— 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                GAD_CONCLUSION  \\\n",
       "0     These results suggest that the C1772T polymorphism in HIF-1alpha is not involved in progression or metastasis of colorectal carcinoma.                                                                                                                                                                     \n",
       "1     In our setting, iron overload among alcoholic individuals seems to be independent of the presence of mutations C282Y, H63D and S65C in the HFE gene.                                                                                                                                                       \n",
       "3     These three studies do not provide consistent evidence supporting the hypothesis that HFE mutations are associated with an increased risk of cardiovascular disease and with the development of arteriosclerosis.                                                                                          \n",
       "5     We conclude that  homozygosity for the G1514-->A mutation is exclusively responsible for the adult form of Sandhoff disease in this family, and that the A619-->G substitution is not a deleterious mutation but rather a common HEXB polymorphism.                                                        \n",
       "8     Our findings suggest that the genetic variants of the TIM-1 but not the TIM-3 gene contribute to asthma susceptibility in this African-American population.                                                                                                                                                \n",
       "13    These findings suggest that individual susceptibility to bladder cancer may be modulated by GSTM1, GSTT1 and NAT2 polymorphisms.                                                                                                                                                                           \n",
       "15    These results support previous reports that the GSTM1 null genotype is associated with a modest increase in risk for lung cancer, particularly among heavy smokers, suggest no role for GSTT1 and the need for further study of GSTP1.                                                                     \n",
       "21    Individuals who bear GSTT1 0/0 genotype or GSTT1 0/0-GSTM1 0/0 combined genotypes are more susceptible to leukemia, especially for male and younger carriers.                                                                                                                                              \n",
       "22    Individuals who bear GSTT1 0/0 genotype or GSTT1 0/0-GSTM1 0/0 combined genotypes are more susceptible to leukemia, especially for male and younger carriers.                                                                                                                                              \n",
       "26    There is a synergy of susceptible genotypes GSTM1 0/0 and CYP1A1 Val/Val or CYP1A1 Ile/Val to enhance the individual susceptibility to lung cancer.                                                                                                                                                        \n",
       "32    Individuals who bear GSTT1 0/0 genotype or GSTT1 0/0-GSTM1 0/0 combined genotypes are more susceptible to leukemia, especially for male and younger carriers.                                                                                                                                              \n",
       "33    Our results through Meta-analysis did not support the association between GSTM1 null genotype and esophageal cancer, but the smokers carring the GSTM1 null genotype might be associated with the increased risk of esophageal cancer.                                                                     \n",
       "34    Our results through Meta-analysis did not support the association between GSTM1 null genotype and esophageal cancer, but the smokers carring the GSTM1 null genotype might be associated with the increased risk of esophageal cancer.                                                                     \n",
       "35    Our results through Meta-analysis did not support the association between GSTM1 null genotype and esophageal cancer, but the smokers carring the GSTM1 null genotype might be associated with the increased risk of esophageal cancer.                                                                     \n",
       "36    Our results through Meta-analysis did not support the association between GSTM1 null genotype and esophageal cancer, but the smokers carring the GSTM1 null genotype might be associated with the increased risk of esophageal cancer.                                                                     \n",
       "39    Because our samples provided quite high power, these results indicate that GSK3B may not play a major role in Japanese schizophrenia.                                                                                                                                                                      \n",
       "44    Examination of our own data and those of other groups leads us to conclude that at present, GRM3 should not be viewed as a gene for which there is replicated evidence for association with schizophrenia.                                                                                                 \n",
       "48    Results indicate that genomic variations of the GRIN1 gene are not likely to be involved substantially in the etiology of schizophrenia.                                                                                                                                                                   \n",
       "49    revealed no significant association between schizophrenia and the SNPs in the upstream region of GRIN1, these SNPs apparently do not play a critical role in the pathogenesis of schizophrenia in the Japanese population.                                                                                 \n",
       "50    revealed no significant association between schizophrenia and the SNPs in the upstream region of GRIN1, these SNPs apparently do not play a critical role in the pathogenesis of schizophrenia in the Japanese population.                                                                                 \n",
       "52    We conclude that  GRIK2 does not play a major role in the pathogenesis of schizophrenia in the Japanese population.                                                                                                                                                                                        \n",
       "53    We conclude that  GRIK2 does not play a major role in the pathogenesis of schizophrenia in the Japanese population.                                                                                                                                                                                        \n",
       "54    We conclude that  GRIK1 does not play a major role in schizophrenia pathogenesis in the Japanese population.                                                                                                                                                                                               \n",
       "55    We conclude that  GRIK1 does not play a major role in schizophrenia pathogenesis in the Japanese population.                                                                                                                                                                                               \n",
       "56    Our results suggest that the three SNPs of GRIA4 are unlikely to play a major role in the susceptibility to schizophrenia in the Chinese population.                                                                                                                                                       \n",
       "58    The result of this study suggests that the GPX1 genotype is unlikely to be associated with the risk of developing prostate cancer.                                                                                                                                                                         \n",
       "67    The results of the current study suggest that genetic polymorphisms in the proximal promoter region and in the fourth intron of the GH1 gene are unrelated to breast carcinoma risk in Chinese women.                                                                                                      \n",
       "70    Overall, we obtained no solid evidence for the involvement of the GDNF gene in the pathogenesis of schizophrenia, although further studies in larger numbers of subjects will be required to conclude whether the trinucleotide repeat polymorphism is associated with the development of schizophrenia.   \n",
       "71    Overall, we obtained no solid evidence for the involvement of the GDNF gene in the pathogenesis of schizophrenia, although further studies in larger numbers of subjects will be required to conclude whether the trinucleotide repeat polymorphism is associated with the development of schizophrenia.   \n",
       "75    Our results suggest that GCK gene was associated with Chinese GDM, and haplotype of GCK1/GCK2 B/2 was a protective factor for GDM.                                                                                                                                                                         \n",
       "...                                                                                                                                  ...                                                                                                                                                                         \n",
       "2745  Thus, TAP1 and TAP2 genes polymorphism are not linked to cervical carcinoma, since no association was found between a particular genotype and the disease.                                                                                                                                                 \n",
       "2746  This pilot study does not support involvement of the GNAS1 polymorphism in prostate cancer risk.                                                                                                                                                                                                           \n",
       "2747  Our findings suggest that the GLO1 gene is unlikely a major susceptible gene for autism in an ethnic Chinese population from Taiwan.                                                                                                                                                                       \n",
       "2748  Thus, TAP1 and TAP2 genes polymorphism are not linked to cervical carcinoma, since no association was found between a particular genotype and the disease.                                                                                                                                                 \n",
       "2749  there is no evidence that either GATA3 rs570613, or any variant in strong linkage disequilibrium with it, is associated with breast cancer risk in women.                                                                                                                                                  \n",
       "2750  Study results do not demonstrate an association between ACE ID polymorphism and colorectal cancer in our patients.                                                                                                                                                                                         \n",
       "2751  our data suggest that GST and CYP1A1 genotypes are not associated with the susceptibility to prostate cancer or its outcome in the Brazilian population.                                                                                                                                                   \n",
       "2754  The results suggest that the CNP gene may not be involved in the etiology and pathology of schizophrenia in the Chinese population.                                                                                                                                                                        \n",
       "2755  These results suggest that the variants within the promoter region of QKI gene are unlikely to play a major role in susceptibility to schizophrenia in the Chinese population.                                                                                                                             \n",
       "2756  trace amine associated receptor 6 is not important for the development of schizophrenia in our family samples.                                                                                                                                                                                             \n",
       "2758  Although rs7566605 was not significantly associated with obesity in our study population, we can not rule out the involvement of INSIG2 in obesity related traits as we found significant association of another tagSNP in INSIG2 with both BMI and ABDCIR.                                                \n",
       "2759  Although rs7566605 was not significantly associated with obesity in our study population, we can not rule out the involvement of INSIG2 in obesity related traits as we found significant association of another tagSNP in INSIG2 with both BMI and ABDCIR.                                                \n",
       "2760  Although rs7566605 was not significantly associated with obesity in our study population, we can not rule out the involvement of INSIG2 in obesity related traits as we found significant association of another tagSNP in INSIG2 with both BMI and ABDCIR.                                                \n",
       "2761  Although rs7566605 was not significantly associated with obesity in our study population, we can not rule out the involvement of INSIG2 in obesity related traits as we found significant association of another tagSNP in INSIG2 with both BMI and ABDCIR.                                                \n",
       "2771  Our findings suggest a relevant role of ADAM33 in thepathogenesis of asthma in this population.                                                                                                                                                                                                            \n",
       "2773  These results do not support the hypothesis that TGFB1 L10P genotypes modify the risk of breast cancer in BRCA1 or BRCA2 mutation carriers.                                                                                                                                                                \n",
       "2776  MnSOD polymorphisms play no role in the genetic predisposition to oesophageal cancer.                                                                                                                                                                                                                      \n",
       "2777  These results do not support the hypothesis that TGFB1 L10P genotypes modify the risk of breast cancer in BRCA1 or BRCA2 mutation carriers.                                                                                                                                                                \n",
       "2778  These results do not support the hypothesis that TGFB1 L10P genotypes modify the risk of breast cancer in BRCA1 or BRCA2 mutation carriers.                                                                                                                                                                \n",
       "2779  There was no evidence of an association between the cSHMT genotype and breast cancer occurrence.                                                                                                                                                                                                           \n",
       "2780  BIK might not play a major role in the susceptibility of schizophrenia in Japanese population.                                                                                                                                                                                                             \n",
       "2781  The present study provides no positive evidence for the association between the RyR3 gene and autism in the Japanese population.                                                                                                                                                                           \n",
       "2782  These results suggest that unlike for other cancer types, the hOGG1 Ser326Cys polymorphism is not a major genetic risk factor for colorectal cancer.                                                                                                                                                       \n",
       "2786  These results suggest that the HSD3B1 N367T and UGT2B17 null polymorphisms may modify the risk of prostate cancer, particularly among men with a family history of the disease.                                                                                                                            \n",
       "2791  This study did not show an association between common variants of CREG and CAD in the northern Chinese Han population.                                                                                                                                                                                     \n",
       "2793  the Trp(64)Arg mutation of ADRB3 has little or no influence on either body weight or body mass index in the general Japanese population.                                                                                                                                                                   \n",
       "2795  Our results suggested that the Val158Met polymorphism of COMT was not associated with the risk of sporadic or latent prostate cancer in Japanese men.                                                                                                                                                      \n",
       "2798  The UGT2B17 deletion polymorphism does not play a major role in prostate cancer susceptibility as previously indicated.                                                                                                                                                                                    \n",
       "2799  Our findings suggest that the p53 codon 72 polymorphism is unlikely to be associated with endometriosis in Japanese women.                                                                                                                                                                                 \n",
       "2800  Our data suggest both TNF and LTA genes are not major susceptibility genes for endometriosis.                                                                                                                                                                                                              \n",
       "\n",
       "     GAD_ASSOC Predicted-CLASS  \n",
       "0     NA        PA              \n",
       "1     NA        PA              \n",
       "3     NA        PA              \n",
       "5     NA        PA              \n",
       "8     PA        NA              \n",
       "13    PA        NA              \n",
       "15    NA        PA              \n",
       "21    PA        NA              \n",
       "22    PA        NA              \n",
       "26    PA        NA              \n",
       "32    PA        NA              \n",
       "33    NA        PA              \n",
       "34    NA        PA              \n",
       "35    NA        PA              \n",
       "36    NA        PA              \n",
       "39    NA        PA              \n",
       "44    NA        PA              \n",
       "48    NA        PA              \n",
       "49    NA        PA              \n",
       "50    NA        PA              \n",
       "52    NA        PA              \n",
       "53    NA        PA              \n",
       "54    NA        PA              \n",
       "55    NA        PA              \n",
       "56    NA        PA              \n",
       "58    NA        PA              \n",
       "67    NA        PA              \n",
       "70    NA        PA              \n",
       "71    NA        PA              \n",
       "75    PA        NA              \n",
       "...   ..        ..              \n",
       "2745  NA        PA              \n",
       "2746  NA        PA              \n",
       "2747  NA        PA              \n",
       "2748  NA        PA              \n",
       "2749  NA        PA              \n",
       "2750  NA        PA              \n",
       "2751  NA        PA              \n",
       "2754  NA        PA              \n",
       "2755  NA        PA              \n",
       "2756  NA        PA              \n",
       "2758  PA        NA              \n",
       "2759  PA        NA              \n",
       "2760  PA        NA              \n",
       "2761  PA        NA              \n",
       "2771  PA        NA              \n",
       "2773  NA        PA              \n",
       "2776  NA        PA              \n",
       "2777  NA        PA              \n",
       "2778  NA        PA              \n",
       "2779  NA        PA              \n",
       "2780  NA        PA              \n",
       "2781  NA        PA              \n",
       "2782  NA        PA              \n",
       "2786  NA        PA              \n",
       "2791  NA        PA              \n",
       "2793  NA        PA              \n",
       "2795  NA        PA              \n",
       "2798  NA        PA              \n",
       "2799  NA        PA              \n",
       "2800  NA        PA              \n",
       "\n",
       "[1039 rows x 3 columns]"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "miss_calssified_GAD_test = GAD_temp.iloc[GAD_miss_classified , [11,2]] \n",
    "miss_calssified_GAD_test['Predicted-CLASS'] = GAD_miss_pred\n",
    "miss_calssified_GAD_test\n",
    "# miss_calssified_GAD_test.to_csv(result_path+'miss_predictions_test.csv')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
